The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The study is being undertaken to understand how a gastric bypass can affect a subject's
diabetes even prior to their losing significant amounts of weight. The hypothesis of this
study is that increased glucagon-like peptide-1 (GLP-1) secretion explains the amelioration
in insulin secretion after Roux-en-Y Gastric Bypass (RYGB) surgery.
Phase:
Early Phase 1
Details
Lead Sponsor:
Adrian Vella
Collaborators:
National Center for Research Resources (NCRR) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)